Table 2. Major genetic changes in HCC samples.
HBV transcripts positive | HBV negative | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HBV-MLL4+ | HBV-MLL4 negative | |||||||||||||||||||||||||||||||||||||||||||||||||
Sample | 315T | 316T | 348T | 351T | 358T | 320T | 328T | 353T | 322T | 363T | 362T | 332T | 317T | 329T | 307T | 312T | 330T | 323T | 360T | 335T | 346T | 354T | 361T | 334T | 345T | 304T | 342T | 350T | 310T | 352T | 311T | 349T | 355T | 314T | 325T | 305T | 319T | 339T | 326T | 327T | 347T | 321T | 333T | 309T | 308T | 337T | 336T | 356T | 359T | 357T |
HBV-MLL4 | ◆ | ◆ | ◆ | ◇ | ◇ | ◇ | ◇ | ◇ | ||||||||||||||||||||||||||||||||||||||||||
TP53 | × | * | * | * | * | * | * | × | × | × | × | × | × | × | × | × | × | × | × | × | × | |||||||||||||||||||||||||||||
CTNNB1 | * | * | * | * | * | * | * | * | * | |||||||||||||||||||||||||||||||||||||||||
c-Met | ○ | ○ |
◆ HBV-MLL4 integration in exon;
◇ HBV-MLL4 integration in intron;
* hotspot mutations, including TP53 R249S and CTNNB1 mutations;
× TP53 non-hotspot mutations;
○ c-Met gene amplificat